Lamotrix

Lamotrigine, the active ingredient in Lamotrix, is an anticonvulsant presented as an oral tablet for oral use. It is used to treat partial seizures, generalized tonic‑clonic seizures and as maintenance therapy for bipolar disorder in adults and adolescents.

GNH USA supplies Lamotrix as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Lamotrigine is employed in the management of seizure disorders and mood stabilization. - Partial seizures: reduces frequency and severity of focal seizure episodes. - Generalized tonic‑clonic seizures: helps control convulsive seizure activity across the brain. - Bipolar disorder (maintenance therapy): stabilizes mood and helps prevent depressive or manic relapse.

Lamotrigine may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Dizziness - Headache - Nausea - Rash - Blurred vision - Fatigue

Serious or Rare Side Effects: - Stevens‑Johnson syndrome or toxic epidermal necrolysis - Severe skin reactions (e.g., bullous eruptions) - Blood dyscrasias such as agranulocytosis or aplastic anemia - Hepatic failure - Suicidal thoughts or behavior - Severe hypersensitivity reactions

When prescribing Lamotrix, clinicians should observe several safety measures. - Dose titration: increase gradually to lower the risk of rash. - Skin reactions: monitor for any rash and discontinue if severe. - Blood counts: periodic monitoring is recommended to detect hematologic abnormalities. - Renal/hepatic impairment: consider dose adjustment based on organ function. - Pregnancy: discuss potential risks and benefits with the prescriber. - Store at ambient temperature: keep in the original pack, protect from moisture and light.

Lamotrigine can interact with several medicines, affecting its plasma levels and safety profile.

Major Interactions (Avoid): - Valproic acid: may raise lamotrigine concentrations, increasing toxicity risk. - Carbamazepine: may lower lamotrigine levels, reducing efficacy. - Phenobarbital: can decrease lamotrigine concentrations, compromising seizure control.

Moderate Interactions (Monitor Closely): - Oral contraceptives: may increase lamotrigine clearance, requiring dose adjustment. - Serotonergic agents: monitor for signs of serotonin syndrome. - Antidepressants (e.g., SSRIs): watch for heightened side‑effect burden.